A phase I trial of biweekly nab-paclitaxel plus ramucirumab in patients with previously treated advanced gastric cancer
- Conditions
- metastatic or recurrent gastric cancer
- Registration Number
- JPRN-UMIN000021949
- Lead Sponsor
- Tokushima University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 10
Not provided
1)patient with allergy of paclitaxel or ramucirumab 2)patient with contraindication for paclitaxel or ramucirumab 3)patient who had previously administered with paclitaxel as first line therapy 4)patient who has a serious infection 5)patient who has serious complications such as heart disease, respitary disorder, cerebrovascular disorder, liver disease and much ascites or pleural effusion 6)patient who has recieved chemotherapy within 2weeks 7)patient who has recieved therapy with blood products 8)patient with other malignat tumor 9)patient with neuropathy (>=grade 2) 10)patient with urinary protein (>=grade 2) 11)patient with brain symptomatic metastasis 12)patient who recieved with steroid 13)patient with psychic disorder 14)patient with pregnancy, lactating or possibility of pregnancy 15)patient who given a dicision of unsuitable for this study by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method